ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 164 filers reported holding ACCELERON PHARMA INC in Q4 2018. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $20,772,000 | +37.8% | 120,700 | +0.5% | 0.01% | +44.4% |
| Q2 2021 | $15,071,000 | -5.1% | 120,100 | +2.6% | 0.01% | -18.2% |
| Q1 2021 | $15,880,000 | +7.8% | 117,100 | +1.7% | 0.01% | +10.0% |
| Q4 2020 | $14,726,000 | +26.2% | 115,100 | +11.0% | 0.01% | +11.1% |
| Q3 2020 | $11,669,000 | +21.0% | 103,700 | +2.5% | 0.01% | +12.5% |
| Q2 2020 | $9,641,000 | +22.7% | 101,200 | +15.8% | 0.01% | 0.0% |
| Q1 2020 | $7,855,000 | +72.3% | 87,400 | +1.6% | 0.01% | +60.0% |
| Q4 2019 | $4,560,000 | +36.9% | 86,000 | +2.0% | 0.01% | +25.0% |
| Q3 2019 | $3,331,000 | -0.9% | 84,300 | +3.1% | 0.00% | 0.0% |
| Q2 2019 | $3,360,000 | -9.6% | 81,800 | +2.5% | 0.00% | 0.0% |
| Q1 2019 | $3,716,000 | +31.1% | 79,800 | +22.6% | 0.00% | 0.0% |
| Q4 2018 | $2,835,000 | -21.6% | 65,100 | +3.0% | 0.00% | 0.0% |
| Q3 2018 | $3,617,000 | +18.0% | 63,200 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $3,066,000 | +16.4% | 63,200 | -6.2% | 0.00% | +33.3% |
| Q1 2018 | $2,635,000 | -0.3% | 67,400 | +8.2% | 0.00% | 0.0% |
| Q4 2017 | $2,644,000 | +13.7% | 62,300 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $2,325,000 | +52.1% | 62,300 | +23.9% | 0.00% | +50.0% |
| Q2 2017 | $1,529,000 | +24.5% | 50,300 | +8.4% | 0.00% | 0.0% |
| Q1 2017 | $1,228,000 | +3.7% | 46,400 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $1,184,000 | -24.4% | 46,400 | +7.2% | 0.00% | -33.3% |
| Q3 2016 | $1,567,000 | +3.0% | 43,300 | -3.3% | 0.00% | +50.0% |
| Q2 2016 | $1,522,000 | +36.5% | 44,800 | +2.3% | 0.00% | 0.0% |
| Q1 2016 | $1,115,000 | -11.0% | 43,800 | +70.4% | 0.00% | -33.3% |
| Q4 2015 | $1,253,000 | +95.8% | 25,700 | 0.0% | 0.00% | +50.0% |
| Q3 2015 | $640,000 | -8.0% | 25,700 | +16.8% | 0.00% | 0.0% |
| Q2 2015 | $696,000 | +15.8% | 22,000 | +39.2% | 0.00% | 0.0% |
| Q1 2015 | $601,000 | +2.2% | 15,800 | +4.6% | 0.00% | 0.0% |
| Q4 2014 | $588,000 | +28.7% | 15,100 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $457,000 | -10.9% | 15,100 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $513,000 | – | 15,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,449,300 | $59,537,000,000 | 6.61% |
| Foresite Capital Management II, LLC | 188,602 | $7,748,000 | 4.36% |
| Foresite Capital Management III, LLC | 254,923 | $10,472,000 | 3.43% |
| Artal Group S.A. | 1,500,000 | $61,620,000 | 2.49% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,305,174 | $53,617,000 | 1.93% |
| Asymmetry Capital Management, L.P. | 82,473 | $3,388,000 | 1.84% |
| QVT Financial LP | 190,977 | $7,845,000 | 1.66% |
| SECTORAL ASSET MANAGEMENT INC | 269,396 | $11,067,000 | 1.32% |
| Sofinnova Investments, Inc. | 241,043 | $9,902,000 | 0.91% |
| Novo Holdings A/S | 119,708 | $4,918,000 | 0.69% |